Pasar al contenido principal

MIMETIZANDO EL SISTEMA INMUNITARIO CONTRA EL CANCER

PID2020-115296RA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 22
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Biohybrid Hydrogels for Tumoroid Culture

  • Castellote-Borrell, Miquel|||0000-0001-7703-2228
  • Merlina, Francesca|||0000-0001-5040-1687
  • Rodríguez, Adrián R.
  • Guasch, Judith|||0000-0002-3571-4711
Tumoroids are 3D in vitro models that recapitulate key features of in vivo tumors, such as their architecture - hypoxic center and oxygenated outer layer - in contrast with traditional 2D cell cultures. Moreover, they may be able to preserve the patient-specific signature in terms of cell heterogeneity and mutations. Tumoroids are, therefore, interesting tools for improving the understanding of cancer biology, developing new drugs, and potentially designing personalized therapeutic plans. Currently, tumoroids are most often established using basement membrane extracts (BME), which provide a multitude of biological cues. However, BME are characterized by a lack of well-defined composition, limited reproducibility, and potential immunogenicity as a consequence of their natural origin. Synthetic polymers can overcome these problems but lack structural and biochemical complexity, which can limit the functional capabilities of organoids. Biohybrid hydrogels consisting of both natural and synthetic components can combine their advantages and offer superior 3D culture systems. In this review, it is summarized efforts devoted to producing tumoroids using different types of biohybrid hydrogels, which are classified according to their crosslinking mechanism.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Lymph-node inspired hydrogels enhance CAR expression and proliferation of CAR T cells

  • Castellote-Borrell, Miquel|||0000-0001-7703-2228
  • Domingo, Marc|||0000-0003-1627-3823
  • Merlina, Francesca|||0000-0001-5040-1687
  • Lu, Huixia|||0000-0003-2731-5283
  • Colell, Salut|||0000-0002-2132-2856
  • Bachiller, Mireia|||0000-0002-6153-4722
  • Juan, Manel|||0000-0002-3064-1648
  • Guedan, Sonia|||0000-0002-9605-0760
  • Faraudo, Jordi|||0000-0002-6315-4993
  • Guasch, Judith|||0000-0002-3571-4711
Chimeric antigen receptor (CAR) T therapy has shown unprecedented results in clinical practice, including long-term complete responses. One of the current challenges of CAR T therapy is to optimize its production in order to lower its cost. Currently, the in vivo activation of T cells by dendritic cells is replicated ex vivo using polymeric magnetic beads coated with antibodies to induce polyclonal T cell activation. However, current practice overlooks the importance of the complex environment that constitutes the lymph nodes, in which T cells activate and proliferate in vivo. Hydrogels are an ideal candidate material for mimicking the properties of natural tissues such as lymph nodes. In this study, key conditions of the composition, stiffness, and microarchitecture of hydrogels were experimentally and theoretically investigated to optimize primary human CAR T cell culture, focusing on CAR expression and proliferation. Poly(ethylene glycol)-heparin hydrogels featuring interconnected pores of 120 μm and an intermediate stiffness of 3.1 kPa were identified as the most suitable conditions for promoting CAR T cell expression and expansion. Specifically, these hydrogels increased the percentage of CAR+ cells by 50% and doubled the replication index compared to suspension cultures. In conclusion, these newly engineered hydrogels are an interesting tool to help improve CAR T cell manufacture and ultimately advance towards a broader clinical implementation of CAR T cell therapy.
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Antibiofilm surfaces based on the immobilization of a novel recombinant antimicrobial multidomain protein using self-assembled monolayers

  • Kyvik, Adriana R.
  • Roca, Ramon
  • Mayolo-Deloisa, Karla
  • Rodriguez Rodriguez, Xavier
  • Martinez-Miguel, Marc
  • Martos, Marta
  • Köber, Mariana
  • Ventosa, Nora
  • Veciana, Jaume
  • Guasch, Judith
  • Garcia-Fruitos, Elena
  • Alomar, Oscar
  • Ratera, Imma
The constant increase of microorganisms resistant to antibiotics has been classified as a global health emergency, which is especially challenging when biofilms are formed. Herein, novel biofunctionalized gold surfaces with the antimicrobial multidomain recombinant protein JAMF1, both in the soluble form and nanostructured as nanoparticles, were developed. The interaction between His-tag termination of the protein and a nitriloacetic acid–Ni complex formed on mixed self-assembled monolayers (mixed SAMs) was exploited. The obtained antibiofilm surfaces based on the immobilization of the novel JAMF1 protein using self-assembled monolayers were characterized using a multi-technique approach including: cyclic voltammetry, X-ray photoelectron spectroscopy, atomic force microscopy and fluorescence, proving that the modification and immobilization of JAMF1 were successfully done. The antibiofilm activity against Escherichia coli and carbapenem-resistant Klebsiella pneumoniae showed that the immobilized antimicrobial proteins were able to reduce biofilm formation of both microorganisms. This strategy opens up new possibilities for controlled biomolecule immobilization for fundamental biological studies and biotechnological applications, at the interface of materials science and molecular biology., info:eu-repo/semantics/publishedVersion
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Activating Thermoplastic Polyurethane Surfaces with Poly(ethylene glycol)-Based Recombinant Human α‑Defensin 5 Monolayers for Antibiofilm Activity

  • Rodríguez Rodríguez, Xavier
  • López-Cano, Adrià
  • Mayolo-Deloisa, Karla
  • Pich, Oscar Q.
  • Bierge, Paula
  • Ventosa, Nora
  • García-de-la-Maria, Cristina
  • Miró, José M.
  • Gasch, Oriol
  • Veciana, Jaume
  • Guasch, Judith
  • Arís, Anna
  • Garcia-Fruitos, Elena
  • Ratera, Imma
  • FUNCATH
Addressing multidrug-resistant microbial infections linked to implantable biomedical devices is an urgent need. In recent years, there has been an active exploration of different surface coatings to prevent and combat drug-resistant microbes. In this research, we present a facile chemical modification of thermoplastic polyurethane (TPU) surfaces with poly(ethylene glycol)-based recombinant human α-defensin 5 (HD5) protein with antimicrobial activity. TPU is one of the most relevant materials used for medical devices with good mechanical properties but also good chemical resistance, which makes it difficult to modify. The chemical modification of TPU surfaces is achieved via a three-step procedure based on (i) TPU activation using hexamethylene diisocyanate (HDI); (ii) interfacial reaction with poly(ethylene glycol) (PEG) derivatives; and finally, (iii) a facile click reaction between the PEG-maleimide terminated assembled monolayers on the TPU and the cysteine (-thiol) termination of the recently designed recombinant human α-defensin 5 (HD5) protein. The obtained PEG based HD5 assembled monolayers on TPU were characterized using a surface science multitechnique approach including scanning electron microscopy, atomic force microscopy, contact angle, and X-ray photoelectron spectroscopy. The modified TPU surfaces with the HD5 protein derivative exhibit broad-spectrum antibacterial properties reducing biofilm formation against Pseudomonas aeruginosa (Gram-negative), methicillin-resistant Staphylococcus aureus (MRSA) (Gram-positive) and methicillin-resistant Staphylococcus epidermidis (MRSE) (Gram-positive). These findings underscore the substantial potential of protein-modified TPU surfaces for applications in combating bacterial infections associated with implantable materials and devices., Financial support by the MICIU of Spain (projects PID2019105622RBI00, PID2020-115296RA-I00, PID2022-137332OBI00, CEX2019-000917-S, CEX2023- 001263-S), CSIC (project 2023AEP092), the Marató de TV3 foundation (project number 201812-30-31-32-33 and 202326-30-31-32-33), and the Generalitat de Catalunya (project SGR Cat 2021-00438 and 2021-01552) is acknowledged. The authors are also grateful for the financial support received from Instituto de Salud Carlos III and the Networking Research Center on Bioengineering, Biomaterials, and Nanomedicine (CIBERBBN). J.G. is grateful to the Max Planck Institute for Medical Research (Heidelberg, Germany) for their collaboration through the Max Planck Partner Group “Dynamic Biomimetics for Cancer Immunotherapy”. ICMAB-CSIC acknowledges support from the Severo Ochoa Programme for Centres of Excellence in R&D (FUNFUTURE, CEX2019-000917-S). J.M.M. received a personal 80:20 research grant from the Institut d’Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain, during 2017−24. This work has been developed inside the Materials Science PhD program of Universitat Autonoma de Barcelona. X.R.R. was supported by a grant PTA2021-020955-I funded by MCIN/AEI/10.13039/ 501100011033 and the FSE. This project has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No. 801342 (Tecniospring INDUSTRY) and the Government of Catalonia’s Agency for Business Competitiveness (ACCIO; TECSPR19-1-0065). A.L.-C. received a predoctoral fellowship from Generalitat de Catalunya (FIAGAUR), and P.B. was supported by a PFIS predoctoral fellowship (FI20/00009) from the Instituto de Salud Carlos III. The authors also acknowledge the ICTS NANBIOSIS for the support of the Biomaterial Processing and Nanostructuring Unit (U6) at ICMAB-CSIC (https://www.nanbiosis.es/ portfolio/u6-biomaterial-processing-and-nanostructuring-unit/, info:eu-repo/semantics/publishedVersion
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

A Novel Generation of Tailored Antimicrobial Drugs Based on Recombinant Multidomain Proteins

  • López-Cano, Adrià
  • Ferrer-Miralles, Neus
  • Sánchez, Julieta
  • Carratalá, Jose Vicente
  • Rodriguez Rodriguez, Xavier
  • Ratera, Imma
  • Guasch, Judith
  • Pich, Oscar Q.
  • Bierge, Paula
  • Garcia-de-la-Maria, Cristina
  • Miro, Jose M.
  • Garcia-Fruitos, Elena
  • Alomar, Oscar
Antibiotic resistance has exponentially increased during the last years. It is necessary to develop new antimicrobial drugs to prevent and treat infectious diseases caused by multidrug- or extensively-drug resistant (MDR/XDR)-bacteria. Host Defense Peptides (HDPs) have a versatile role, acting as antimicrobial peptides and regulators of several innate immunity functions. The results shown by previous studies using synthetic HDPs are only the tip of the iceberg, since the synergistic potential of HDPs and their production as recombinant proteins are fields practically unexplored. The present study aims to move a step forward through the development of a new generation of tailored antimicrobials, using a rational design of recombinant multidomain proteins based on HDPs. This strategy is based on a two-phase process, starting with the construction of the first generation molecules using single HDPs and further selecting those HDPs with higher bactericidal efficiencies to be combined in the second generation of broad-spectrum antimicrobials. As a proof of concept, we have designed three new antimicrobials, named D5L37βD3, D5L37D5L37 and D5LAL37βD3. After an in-depth exploration, we found D5L37D5L37 to be the most promising one, since it was equally effective against four relevant pathogens in healthcare-associated infections, such as methicillin-susceptible (MSSA) and methicillin-resistant (MRSA) Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis (MRSE) and MDR Pseudomonas aeruginosa, being MRSA, MRSE and P. aeruginosa MDR strains. The low MIC values and versatile activity against planktonic and biofilm forms reinforce the use of this platform to isolate and produce unlimited HDP combinations as new antimicrobial drugs by effective means., info:eu-repo/semantics/publishedVersion
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Enhanced human T cell expansion with inverse opal hydrogels

  • Santos, Fabiao
  • Valderas Gutiérrez, Julia
  • Pérez del Río, Eduardo
  • Castellote Borrell, Miquel
  • Rodríguez Rodríguez, Xavier
  • Veciana, Jaume
  • Ratera, Immaculada
  • Guasch, Judit
Advanced personalized immunotherapies still have to overcome several biomedical and technical limitations before they become a routine cancer treatment in spite of recent achievements. In adoptive cell therapy (ACT), the capacity to obtain adequate numbers of therapeutic T cells in the patients following ex vivo treatment should be improved. Moreover, the time and costs to produce these T cells should be reduced. In this work, inverse opal (IOPAL) 3D hydrogels consisting of poly(ethylene) glycol (PEG) covalently combined with heparin were engineered to resemble the environment of lymph nodes, where T cells get activated and proliferate. The introduction of an IOPAL strategy allowed a precise control on the porosity of the hydrogels, providing an increase in the proliferation of primary human CD4+ T cells, when compared with state-of-the-art expansion systems. Additionally, the IOPAL hydrogels also showed a superior expansion compared to hydrogels with the same composition, but without the predetermined pore structure. In summary, we have shown the beneficial effect of having an IOPAL architecture in our 3D hydrogels to help achieving large numbers of cells, while maintaining the desired selected phenotypes required for ACT., We acknowledge D. P. Rosenblatt for proofreading this manuscript and “Servei de Microscòpia” from UAB for assistance in the confocal microscopy. This work has been developed inside the “Materials Science” PhD program of UAB. The authors are grateful for the financial support received from the Spanish Government (PID2020-115296RA-I00, PID2019-105622RBI00, and the “Ramón y Cajal” program (RYC-2017-22614)), the Networking Research Center on Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN) through the projects “Alycia” (No. BBN18PI01) and “Gels4ACT” (No. BBN20PIV02), as well as CSIC for a JAE Intro fellowship. The work was funded as well by the Max Planck Society through the Max Planck Partner Group “Dynamic Biomimetics for Cancer Immunotherapy” in collaboration with the Max Planck for Medical Research (Heidelberg, Germany). This research was also supported by the European Union's Horizon 2020 research and innovation programme H2020-MSCA-COFUND-2016 (DOC-FAM, grant agreement no. 754397). ICMAB-CSIC acknowledges support from the Severo Ochoa programme for centres of excellence in R&D (FUNFUTURE, CEX2019-000917-S)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Hierarchical Quatsome-RGD Nanoarchitectonic Surfaces for Enhanced Integrin-Mediated Cell Adhesion

  • Martínez Miguel, Marc
  • Castellote Borrell, Miquel
  • Köber, Mariana
  • Kyvik Ruiz, Adriana
  • Tomsen Melero, Judit
  • Vargas Nadal, Guillem
  • Muñoz Martín, José M.
  • Pulido, Daniel
  • Cristóbal Lecina, Edgar
  • Passemard, Solène
  • Royo, Miriam
  • Mas Torrent, Marta
  • Veciana, Jaume
  • Giannotti, Marina I.
  • Guasch, Judit
  • Ventosa, Nora
  • Ratera, Immaculada
The synthesis and study of the tripeptide Arg-Gly-Asp (RGD), the binding site of different extracellular matrix proteins, e.g., fibronectin and vitronectin, has allowed the production of a wide range of cell adhesive surfaces. Although the surface density and spacing of the RGD peptide at the nanoscale have already shown a significant influence on cell adhesion, the impact of its hierarchical nanostructure is still rather unexplored. Accordingly, a versatile colloidal system named quatsomes, based on fluid nanovesicles formed by the self-assembling of cholesterol and surfactant molecules, has been devised as a novel template to achieve hierarchical nanostructures of the RGD peptide. To this end, RGD was anchored on the vesicle's fluid membrane of quatsomes, and the RGD-functionalized nanovesicles were covalently anchored to planar gold surfaces, forming a state of quasi-suspension, through a long poly(ethylene glycol) (PEG) chain with a thiol termination. An underlying self-assembled monolayer (SAM) of a shorter PEG was introduced for vesicle stabilization and to avoid unspecific cell adhesion. In comparison with substrates featuring a homogeneous distribution of RGD peptides, the resulting hierarchical nanoarchitectonic dramatically enhanced cell adhesion, despite lower overall RGD molecules on the surface. The new versatile platform was thoroughly characterized using a multitechnique approach, proving its enhanced performance. These findings open new methods for the hierarchical immobilization of biomolecules on surfaces using quatsomes as a robust and novel tissue engineering strategy., This work was supported by MICINN (PID2019-105622RBI00, MAT2016-80826-R, PID2019-111682RB-I00, PID2020-115296RA-I00, CTQ2015-66194-R; SAF2014-60138-R, RTI2018-093831-B-I00, and PDC2021-121481-I00); Instituto de Salud Carlos III (ISCIII) through the Networking Research Center on Bioengineering, Biomaterials and Nanomedicine, CIBER-BBN (FlexQS-skin, FlexCAB, BBN18PI01, BBN20PIV02, and CB/06/0074); Generalitat de Catalunya (grants 2017-SGR-918, 2017-SGR-229, 2017-SGR-1442, 2017-SGR-1439); the Fundació Marató de TV3 (Nr. 201812); the COST Action CA15126 Between Atom and Cell, and “ERDF A way of making Europe”. J.G. acknowledges financial support from the Ramón y Cajal Program (RYC-2017-22614) from MICINN and the Max Planck Society through the Max Planck Partner Group “Dynamic Biomimetics for Cancer Immunotherapy” in collaboration with the Max Planck Institute for Medical Research (Heidelberg, Germany). This work has received funding from the European Union’s Horizon 2020 research and innovation program through grant agreements 953110 (PHOENIX), 720942 (Smart4Fabry), 101007804 (MICRO4NANO), and 801342 (granted to the Agency for Business Competitiveness ACCIÓ through a Tecniospring Industry fellowship (TECSPR19-1-0065)). ICMAB acknowledges support from MICINN through the “‘Severo Ochoa”’ Programme for Centres of Excellence in R&D (CEX2019-000917-S). J.M. acknowledges a “Juan de la Cierva” fellowship from MICINN. J.T-M. acknowledges an FI-AGAUR grant (2020FI_B2 00137) from Generalitat de Catalunya and the European Social Fund. We also acknowledge the ICTS “NANBIOSIS for the support of the Synthesis of Peptides Unit (U3) at IQAC–CSIC (https://www.nanbiosis.es/portfolio/u3-synthesis-of-peptides-unit/) and the Biomaterial Processing and Nanostructuring Unit (U6) at ICMAB-CSIC (https://www.nanbiosis.es/portfolio/u6-biomaterial-processing-and-nanostructuring-unit/). We are grateful to the SMP unit of the Scientific and Technological Centers of University of Barcelona (CCiTUB). This work has been developed under the “Biochemistry, Molecular Biology and Biomedicine” and “Materials Science” Ph.D. programs of Universitat Autònoma de Barcelona (UAB)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A novel generation of tailored antimicrobial drugs based on recombinant multidomain proteins

  • López Cano, Adrià
  • Ferrer Miralles, Neus
  • Sánchez, Julieta
  • Carratalá, Jose Vicente
  • Rodríguez Rodríguez, Xavier
  • Ratera, Immaculada
  • Guasch, Judit
  • Pich, Oscar Q.
  • Bierge, Paula
  • Garcia de la María, Cristina
  • Miro, Jose M.
  • García Fruitós, Elena
  • Arís, Anna
Antibiotic resistance has exponentially increased during the last years. It is necessary to develop new antimicrobial drugs to prevent and treat infectious diseases caused by multidrug- or extensively-drug resistant (MDR/XDR)-bacteria. Host Defense Peptides (HDPs) have a versatile role, acting as antimicrobial peptides and regulators of several innate immunity functions. The results shown by previous studies using synthetic HDPs are only the tip of the iceberg, since the synergistic potential of HDPs and their production as recombinant proteins are fields practically unexplored. The present study aims to move a step forward through the development of a new generation of tailored antimicrobials, using a rational design of recombinant multidomain proteins based on HDPs. This strategy is based on a two-phase process, starting with the construction of the first generation molecules using single HDPs and further selecting those HDPs with higher bactericidal efficiencies to be combined in the second generation of broad-spectrum antimicrobials. As a proof of concept, we have designed three new antimicrobials, named D5L37βD3, D5L37D5L37 and D5LAL37βD3. After an in-depth exploration, we found D5L37D5L37 to be the most promising one, since it was equally effective against four relevant pathogens in healthcare-associated infections, such as methicillin-susceptible (MSSA) and methicillin-resistant (MRSA) Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis (MRSE) and MDR Pseudomonas aeruginosa, being MRSA, MRSE and P. aeruginosa MDR strains. The low MIC values and versatile activity against planktonic and biofilm forms reinforce the use of this platform to isolate and produce unlimited HDP combinations as new antimicrobial drugs by effective means., This work was funded by the Ministerio de Ciencia, Innovación y Universidades grants (PID2019-107298RB-C21/AEI/10.13039/501100011033; PID2019-105622RBI00; PID2020-115296RA-I00; RYC-2017-22614), by Marató de TV3 foundation (201812-30-31-32-33). We also thank the Instituto de Salud Carlos III (ISCIII) through the Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN). The authors are also indebted to the CERCA Program (Generalitat de Catalunya) and European Social Fund for supporting our research. JMS is supported with a María Zambrano postdoctoral researcher contract (677904) from Ministerio de Universidades and European Union (“Financed by European Union-Next GenerationEU”). AL-C received a pre-doctoral fellowship from Generalitat de Catalunya (FI-AGAUR) and EG-F a post-doctoral fellowship from INIA (DOC-INIA). J.G. acknowledges financial support from the Max Planck Society through the Max Planck Partner Group “Dynamic Biomimetics for Cancer Immunotherapy” in collaboration with the Max Planck Institute for Medical Research (Heidelberg, Germany). ICMAB acknowledges support from the MICINN through the ‘‘Severo Ochoa’’ Program for Centers of Excellence in R&D (CEX2019-000917-S). JMM received a personal 80:20 research grant from the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain, during 2017–23., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2019-000917-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Electroactive substrates for surface-enhanced Raman spectroscopy based on overgrown gold-nanoparticle arrays by electrodeposition on indium tin oxide

  • Gonzalez Pato, Nerea 
  • Rodríguez Rodríguez, Xavier
  • Pellizzi, Nicola
  • Fasolato, Claudia
  • Guasch, Judit
  • Postorino, Paolo
  • Veciana, Jaume
  • Goñi, Alejandro R.
  • Ratera, Immaculada
We report an easy and low-cost method for the preparation of highly homogeneous electroactive substrates that can be used simultaneously for surface-enhanced Raman spectroscopy (SERS) and electrochemical measurements. The choice of conductive indium tin oxide (ITO) as a substrate is based on its excellent electrical conductivity and transparency. However, its typically high roughness makes the subsequent metal deposition with traditional methods very challenging, making them time-consuming and costly. To circumvent this problem, we developed a simple two-step procedure consisting of first the deposition of a quasi-hexagonal pattern of homogeneously distributed gold nanoparticles (AuNPs) by block-copolymer micellar lithography on ITO. Subsequently, the AuNPs act as seeds for further gold growth by electrodeposition on the pre-patterned ITO substrate. In this way, we reproducibly achieved substrates (>50) with an average gold coverage of (40 ± 5) % and many hot spots due to a small average inter-particle distance of (15 ± 5) nm. These substrates exhibit a strong and homogeneous Raman signal, as determined using 2D maps obtained with the standard Raman tag molecule 4-mercaptobenzoic acid. Moreover, the electrochemical performance of the developed conductive SERS substrates was demonstrated using a Michael addition reaction monitored by Raman scattering. This reaction occurs between the hydroquinone/benzoquinone redox pair and a biologically relevant analyte, but only takes place in one of the redox states of the hydroquinone/benzoquinone system., The authors appreciate the financial support of the Spanish Government through the grants MOTHER (MAT2016-80826-R), Mol4Bio (PID2019-105622RBI00), Immunys (PID2020-115296RA-I00) and the “Ramón y Cajal” program (RYC-2017-22614). Additionally, ICMAB acknowledges support from the Spanish Ministry of Science and Innovation through the “Severo Ochoa” Programme for Centres of Excellence in R & D (CEX2019-000917-S). The authors are also grateful to the Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN; projects “Alycia” (No. BBN18PI01) and “Gels4ACT” (No. BBN20PIV02)). Fundació Marató de TV3 (No. 201812) and Generalitat de Catalunya (SGR Cat 2021 - 00438) are also acknowledged. The work was funded as well by the Max Planck Society through the Max Planck Partner Group “Dynamic Biomimetics for Cancer Immunotherapy” in collaboration with the Max Planck for Medical Research (Heidelberg, Germany). N. G. P. is enrolled in the Materials Science PhD program of Universitat Autònoma de Barcelona (UAB) and acknowledges the financial support from the FPU fellowship (FPU17/02551) from the Spanish Ministry. N. P. acknowledges Regione Lazio for financial support for the stay at ICMAB through the “Torno Subito” programme., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Antibiofilm surfaces based on the immobilization of a novel recombinant antimicrobial multidomain protein using self-assembled monolayers

  • Kyvik Ruiz, Adriana
  • Roca-Pinilla, Ramon
  • Mayolo Deloisa, Karla P.
  • Rodríguez Rodríguez, Xavier
  • Martinez Miguel, Marc 
  • Martos, Marta
  • Köber, Mariana
  • Ventosa, Nora
  • Veciana, Jaume
  • Guasch, Judit
  • Garcia Fruitós, Elena
  • Arís, Anna
  • Ratera, Immaculada
The constant increase of microorganisms resistant to antibiotics has been classified as a global health emergency, which is especially challenging when biofilms are formed. Herein, novel biofunctionalized gold surfaces with the antimicrobial multidomain recombinant protein JAMF1, both in the soluble form and nanostructured as nanoparticles, were developed. The interaction between His-tag termination of the protein and a nitriloacetic acid-Ni complex formed on mixed self-assembled monolayers (mixed SAMs) was exploited. The obtained antibiofilm surfaces based on the immobilization of the novel JAMF1 protein using self-assembled monolayers were characterized using a multi-technique approach including: cyclic voltammetry, X-ray photoelectron spectroscopy, atomic force microscopy and fluorescence, proving that the modification and immobilization of JAMF1 were successfully done. The antibiofilm activity against Escherichia coli and carbapenem-resistant Klebsiella pneumoniae showed that the immobilized antimicrobial proteins were able to reduce biofilm formation of both microorganisms. This strategy opens up new possibilities for controlled biomolecule immobilization for fundamental biological studies and biotechnological applications, at the interface of materials science and molecular biology., This work has been developed under the Biochemistry and Biomedicine and Materials Science Program of Universitat Autònoma de Barcelona (UAB). The characterization has been performed by the ICTS ‘‘NANBIOSIS’’, more specifically by the Biomaterial Processing and Nanostructuring Unit (U6), Unit of CIBER-BBN located at ICMAB-CSIC. Authors are grateful for the financial support received from MICINN (PID2020-115296RA-I00 and PID2019–105622RB-I00), the Networking Research Center on Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), GenCat (grant 2017-SGR-918, SGR Cat 2021-00438 and CERCA programme), the European Social Fund, and Fundació La Marató de TV3 (Nr. 201812). This project has received funding from the European Union's Horizon 2020 research and innovation program under the HORIZON-RIA project NABIHEAL (GA number 101092269), the Marie Skłodowska-Curie grant agreement No. 801342 (Tecniospring INDUSTRY) and the Government of Catalonia's Agency for Business Competitiveness (ACCIÓ; TECSPR19-1-0065). J.G. is grateful to MICINN for a ‘‘Ramón y Cajal’’ fellowship (RYC-2017-22614) as well as to the Max Planck Society through the Max Planck Partner Group “Dynamic Biomimetics for Cancer Immunotherapy” in collaboration with the Max Planck Institute for Medical Research (Heidelberg, Germany). R.R-P received a PhD fellowship from Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement de la Generalitat de Catalunya (AGAUR) and E.G-F a post-doctoral fellowship from INIA (DOC-INIA). ICMAB-CSIC acknowledges the support from the Severo Ochoa Programme for Centres of Excellence in R&D (FUNFUTURE, CEX2019-000917-S). Table of contents entry and Fig. 2 were designed with BioRender.com., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Ratiometric Nanothermometer Based on a Radical Excimer for In Vivo Sensing

  • Blasi, Davide
  • Gonzalez Pato, Nerea 
  • Rodríguez Rodríguez, Xavier
  • Díez Zabala, Íñigo
  • Srinivasan, Sumithra Y.
  • Camarero, Núria
  • Esquivias, Oriol
  • Roldán, Mònica
  • Guasch, Judit
  • Laromaine, Anna
  • Gorostiza, Pau
  • Veciana, Jaume
  • Ratera, Immaculada
Ratiometric fluorescent nanothermometers with near-infrared emission play an important role in in vivo sensing since they can be used as intracellular thermal sensing probes with high spatial resolution and high sensitivity, to investigate cellular functions of interest in diagnosis and therapy, where current approaches are not effective. Herein, the temperature-dependent fluorescence of organic nanoparticles is designed, synthesized, and studied based on the dual emission, generated by monomer and excimer species, of the tris(2,4,6-trichlorophenyl)methyl radical (TTM) doping organic nanoparticles (TTMd-ONPs), made of optically neutral tris(2,4,6-trichlorophenyl)methane (TTM-αH), acting as a matrix. The excimer emission intensity of TTMd-ONPs decreases with increasing temperatures whereas the monomer emission is almost independent and can be used as an internal reference. TTMd-ONPs show a great temperature sensitivity (3.4% K-1 at 328 K) and a wide temperature response at ambient conditions with excellent reversibility and high colloidal stability. In addition, TTMd-ONPs are not cytotoxic and their ratiometric outputs are unaffected by changes in the environment. Individual TTMd-ONPs are able to sense temperature changes at the nano-microscale. In vivo thermometry experiments in Caenorhabditis elegans (C. elegans) worms show that TTMd-ONPs can locally monitor internal body temperature changes with spatio-temporal resolution and high sensitivity, offering multiple applications in the biological nanothermometry field., D.B. and N.G.-P. contributed equally to this work. The authors are grateful for the financial support received from the Spanish Government (PID2020-115296RA-I00, PID2019-105622RB-I00, PDI2021-122645OB-I00, RTI2018-096273-B-I00 and PID2019-111493RB-I00) funded by MICIN and the “Ramón y Cajal” program (RYC-2017-22614), the Generalitat de Catalunya (SGR-918, 2017SGR765, SGR Cat 2021-00438, 2017-SGR-1442, and 2021-SGR-1410, 2021-SGR-00446), and the Networking Research Center on Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN). DB gratefully acknoledges the REFIN (Return for Future Innovation) action for funding, an ininitiative co - funded by European Union through the POR Puglia 2014 - 2020 (ID grant: 2455F798). This research was also supported by the European Union's Horizon 2020 research and innovation program H2020-MSCA-COFUND-2016 (DOC-FAM, grant agreement Nr. 754397), Human Brain Project WaveScaES (SGA2-785907 and SGA3-945539), DEEPER (ICT36-2020-101016787), and the Marie Skłodowka-Curie grant agreement Nr. 101007804 (Micro4Nano). Support from Fundaluce and CaixaHealth (ID 100010434) are also acknowledged. The work was supported as well by the Max Planck Society through the Max Planck Partner Group “Dynamic Biomimetics for Cancer Immunotherapy” in collaboration with the Max Planck for Medical Research (Heidelberg, Germany). ICMAB-CSIC acknowledges support from the Severo Ochoa Programme for Centres of Excellence in R&D (FUNFUTURE, CEX2019-000917-S). IBEC acknowledges support from the CERCA programme of AGAUR/Generalitat de Catalunya and the Severo Ochoa Programme. This work had been developed inside the “Biochemistry, Molecular Biology and Biomedicine” and “Materials Science” Ph.D. programs of UAB. Nerea Gonzalez-Pato acknowledges the financial support from the FPU fellowship (FPU17/02551) from the Spanish Ministry., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Biohybrid Hydrogels for Tumoroid Culture

  • Castellote Borrell, Miquel
  • Merlina, Francesca
  • Rodríguez, Adrián R.
  • Guasch, Judit
Tumoroids are 3D in vitro models that recapitulate key features of in vivo tumors, such as their architecture - hypoxic center and oxygenated outer layer - in contrast with traditional 2D cell cultures. Moreover, they may be able to preserve the patient-specific signature in terms of cell heterogeneity and mutations. Tumoroids are, therefore, interesting tools for improving the understanding of cancer biology, developing new drugs, and potentially designing personalized therapeutic plans. Currently, tumoroids are most often established using basement membrane extracts (BME), which provide a multitude of biological cues. However, BME are characterized by a lack of well-defined composition, limited reproducibility, and potential immunogenicity as a consequence of their natural origin. Synthetic polymers can overcome these problems but lack structural and biochemical complexity, which can limit the functional capabilities of organoids. Biohybrid hydrogels consisting of both natural and synthetic components can combine their advantages and offer superior 3D culture systems. In this review, it is summarized efforts devoted to producing tumoroids using different types of biohybrid hydrogels, which are classified according to their crosslinking mechanism., The authors acknowledge D. P. Rosenblatt for proofreading this manuscript. This work was funded by the Spanish Ministry of Science and Innovation through the “Ramón y Cajal” Programme (RYC-2017-22614), the project PID2020-115296RA-I00 and the “Severo Ochoa” Programme for Centres of Excellence in R&D (CEX2019-000917-S). Additionally, it has been supported by the Max Planck Society through the Max Planck Partner Group “Dynamic Biomimetics for Cancer Immunotherapy” in collaboration with the Max Planck for Medical Research (Heidelberg, Germany). This research was also funded by Instituto de Salud Carlos III through Consorcio Centro de Investigación Biomédica en Red (CIBER) with the projects “Alycia” (Nr. BBN18PI01) and “Gels4ACT” (Nr. BBN20PIV02). This work has been developed inside the “Materials Science” Ph.D. program of UAB., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Three-dimensional cell culture of chimeric antigen receptor T cells originated from peripheral blood mononuclear cells towards cellular therapies

  • Pérez del Río, Eduardo
  • Román Alonso, Macarena
  • Rius, Irene
  • Santos, Fabiao
  • Castellote Borrell, Miquel
  • Veciana, Jaume
  • Ratera, Immaculada
  • Arribas, Joaquín
  • Guasch, Judit
Background aims: With the objective of improving the ex vivo production of therapeutic chimeric antigen receptor (CAR) T cells, we explored the addition of three-dimensional (3D) polystyrene scaffolds to standard suspension cell cultures.Methods: We aimed to mimic the structural support given by the lymph nodes during in vivo lymphocyte expansion.Results: We observed an increase in cell proliferation compared with standard suspension systems as well as an enhanced cytotoxicity toward cancer cells. Moreover, we directly obtained the CART cells from peripheral blood mononuclear cells, thus minimizing the ex vivo manipulation of the therapeutic cells and opening the way to synergies among different cell populations.Conclusions: We propose the use of commercially available 3D polystyrene systems to improve the current immune cell cultures and resulting cell products for emerging cellular (immuno)therapies.(c) 2023 International Society for Cell & Gene Therapy., This research was funded by Instituto de Salud Carlos III through Consorcio Centro de Investigación Biomédica en Red (CIBER) with the projects “Alycia” (Nr. BBN18PI01) and “Gels4ACT” (Nr. BBN20PIV02). The authors are also grateful for the financial support received from the Spanish Ministry of Science and Innovation (PID2020-115296RA-I00, PID2019-105622RBI00 and the “Ramón y Cajal” program [RYC-2017-22614]). The work was supported as well by the Max Planck Society through the Max Planck Partner Group “Dynamic Biomimetics for Cancer Immunotherapy” in collaboration with the Max Planck for Medical Research (Heidelberg, Germany). This research was also supported by the European Union's Horizon 2020 research and innovation programme H2020-MSCA-COFUND-2016 (DOC-FAM, grant agreement Nr. 754397). The authors acknowledge financial support from the Spanish Ministry of Science and Innovation through the “Severo Ochoa” Programme for Centres of Excellence in R&D (CEX2019-000917-S)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

pH-Sensitive Acrylic Terpolymers for the Coating of Orally Administered Drugs Used for Colonic Release

  • Suárez, Lina M.
  • Hoyos, Lina
  • Castellote Borrell, Miquel
  • Guasch, Judit
  • Orozco, Víctor H.
  • Arias Giraldo, Luis F.
Polymeric coatings are a promising option for the development of delivery systems for orally administered drugs. However, the gastrointestinal conditions to which they are subjected, which include low pH and solubility as well as peristaltic movements, can limit their applications. In this work, different formulations of polymeric coatings were produced using pH-sensitive materials consisting of copolymers of methyl acrylate, methyl methacrylate, and methacrylic acid. The polymers were synthesized by the emulsion polymerization technique, obtaining small average particle sizes (56-190 nm), molecular weights between 200,000 and 400,000 g/mol, and a glass transition temperature above 35 °C, which are suitable for film formation at room temperature. Thus, they were assessed as coatings for hydroxypropyl methylcellulose capsules (HPMC) using the immersion method, showing adequate capacity to protect the capsule at gastric pH (pH 1.2) and dissolve at the simulated intestinal pH (pH= 7.2). In particular, the higher the content of the acidic monomer, the higher the release time of the test molecule contained in the acrylic terpolymer-coated HPMC capsules proposed, which was a curcuminoid derivative due to their bright color and potential medical benefits. In addition, a minimum number of immersions was required for coating the HPMC capsules at high acidic concentrations, which further facilitates the delayed release needed for colonic treatment. However, too high proportions of methacrylic acid may result in cytotoxicity issues. Consequently, a biocompatible formulation containing a proportion of methyl acrylate, methyl methacrylate, and methacrylic acid of 7:3:3 is proposed as the most adequate for colonic release. Thus, by chemically modulating the molar percentages of the acrylic monomers, it was possible to obtain tailored acrylic terpolymer coatings with different characteristics and desired properties in order to modulate the release kinetics of an active substance in a colonic environment., The authors thank D. P. Rosenblatt for proofreading the manuscript. The work was funded by the University of Antioquia, MINCIENCIAS through the program Ecosistema Cientifico (Alianza NanoBiocáncer Cod. FP44842-211-2018, project number 58962). Instituto de Salud Carlos III funded this research through Consorcio Centro de Investigación Biomédica en Red (CIBER) with the project “Gels4ACT” (Nr. BBN20PIV02). The authors are also grateful for the financial support received from the Spanish Ministry of Science and Innovation (PID2020-115296RA-I00 and the “Ramón y Cajal” program (RYC-2017-22614)). The work was also supported by the Max Planck Society through the Max Planck Partner Group “Dynamic Biomimetics for Cancer Immunotherapy” in collaboration with the Max Planck Institute for Medical Research (Heidelberg, Germany). The authors acknowledge financial support from the Spanish Ministry of Science and Innovation through the “Severo Ochoa” Programme for Centres of Excellence in R&D (CEX2019-000917-S). This work has been developed inside the “Materials Science” PhD program of UAB (Spain)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Migration of human T cells can be differentially directed by electric fields depending on the extracellular microenvironment

  • Ende, Karen
  • Santos, Fabião
  • Guasch, Judit
  • Kemkemer, Ralf
T cell migration plays an essential role in the immune response and T cell-based therapies. It can be modulated by chemical and physical cues such as electric fields (EFs). The mechanisms underlying electrotaxis (cell migration manipulated by EFs) are not fully understood and systematic studies with immune cells are rare. In this in vitro study, we show that direct current EFs with strengths of physiologically occurring EFs (25-200 mV/mm) can guide the migration of primary human CD4+ and CD8+ T cells on 2D substrates toward the anode and in a 3D environment differentially (CD4+ T cells show cathodal and CD8+ T cells show anodal electrotaxis). Overall, we find that EFs present a potent stimulus to direct T cell migration in different microenvironments in a cell-type-, substrate-, and voltage-dependent manner, while not significantly influencing T cell differentiation or viability., We thank Prof. Dr. Katja Schenke-Layland (Eberhard Karls University Tübingen) for her support and the helpful discussion of the results. We also thank Dr. Imma Ratera (ICMAB-CSIC) for her support with the supervision of F.S. thesis. We are grateful to the FACS Core Facility Berg of the University Clinic Tübingen, for technical support and the use of the shared flow cytometry instrument FACS Canto II (BD Biosciences) for flow cytometry sample acquisition. We acknowledge the Institute for Clinical Transfusion Medicine in Tübingen (Project No.: 201809-2009-01 and ZKT-FoPro202105-2212-01) for providing us with human buffy coats and the Ethics Committee of the University Clinic Tübingen for the ethical approval of our study (Project No.: 581/2018BO2). R.K. and K.E. are grateful for support by Reutlingen University. R.K., J.G., and K.E. acknowledge support by the Max Planck Society. In particular, J.G. is grateful to the Max Planck Institute for Medical Research (Heidelberg, Germany) for their collaboration through the Max Planck Partner Group “Dynamic Biomimetics for Cancer Immunotherapy.” J.G. also acknowledges support from CIBER-BBN and the Spanish Ministry of Science and Innovation through the “Ramón y Cajal” Program ( RYC-2017-22614 ), the project PID2020-115296RA-I00 , and the “Severo Ochoa” Program for Centers of Excellence in R&D ( CEX2019-000917-S ). This work was also funded by the European Union’s Horizon 2020 research and innovation program H2020-MSCA-COFUND-2016 (DOC-FAM, grant agreement Nr. 754397 )., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

3D Printing as a Strategy to Scale-Up Biohybrid Hydrogels for T Cell Manufacture

  • Pérez Del Río, Eduardo
  • Rey Vinolas, Sergi
  • Santos, Fabião
  • Castellote Borrell, Miquel
  • Merlina, Francesca
  • Veciana, Jaume
  • Ratera, Immaculada
  • Mateos Timoneda, Miguel A.
  • Engel, Elisabeth
  • Guasch, Judith
The emergence of cellular immunotherapy treatments is introducing more efficient strategies to combat cancer as well as autoimmune and infectious diseases. However, the cellular manufacturing procedures associated with these therapies remain costly and time-consuming, thus limiting their applicability. Recently, lymph-node-inspired PEG-heparin hydrogels have been demonstrated to improve primary human T cell culture at the laboratory scale. To go one step further in their clinical applicability, we assessed their scalability, which was successfully achieved by 3D printing. Thus, we were able to improve primary human T cell infiltration in the biohybrid PEG-heparin hydrogels, as well as increase nutrient, waste, and gas transport, resulting in higher primary human T cell proliferation rates while maintaining the phenotype. Thus, we moved one step further toward meeting the requirements needed to improve the manufacture of the cellular products used in cellular immunotherapies., This research was funded by the Spanish Ministry of Science and Innovation (PID2020-115296RA-I00; PID2019-105622RB-I00; PID2021-128412OB-I00 European Union NextGenerationEU/PRTR, and the “Ramón y Cajal” program (RYC-2017-22614)) as well as the Generalitat de Catalunya (SGRCat 2021-00438; 2017-SGR-359; Tecnologies Emergents program of the General Directorate for Research – Nr. 001-P-001646, cofunded with FEDER Operational Program of Catalonia 2014–2020). The work was also supported by the Max Planck Society through the Max Planck Partner Group “Dynamic Biomimetics for Cancer Immunotherapy” in collaboration with the Max Planck Institute for Medical Research (Heidelberg, Germany). The authors are grateful for the financial support received from Instituto de Salud Carlos III through Consorcio Centro de Investigación Biomédica en Red (CIBER) with the project “Gels4ACT” (Nr. BBN20PIV02). This research was also supported by the European Union’s Horizon 2020 research and innovation program H2020-MSCA-COFUND-2016 (DOC-FAM, grant agreement Nr. 754397). The authors acknowledge financial support from the Spanish Ministry of Science and Innovation through the “Severo Ochoa” Program for Centres of Excellence in R&D (CEX2023-001263-S, CEX2019-000917-S and CEX2018-000789-S)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S). With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2023-001263-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Activating Thermoplastic Polyurethane Surfaces with Poly(ethylene glycol)-Based Recombinant Human α-Defensin 5 Monolayers for Antibiofilm Activity

  • Rodríguez Rodríguez, Xavier
  • López Cano, Adrià
  • Mayolo Deloisa, Karla P.
  • Pich, Oscar Q.
  • Bierge, Paula
  • Ventosa, Nora
  • García-de-la-Maria, Cristina
  • Miró, José M.
  • Gasch, Oriol
  • Veciana, Jaume
  • Guasch, Judith
  • Arís, Anna
  • Garcia Fruitós, Elena
  • Ratera, Immaculada
Addressing multidrug-resistant microbial infections linked to implantable biomedical devices is an urgent need. In recent years, there has been an active exploration of different surface coatings to prevent and combat drug-resistant microbes. In this research, we present a facile chemical modification of thermoplastic polyurethane (TPU) surfaces with poly(ethylene glycol)-based recombinant human α-defensin 5 (HD5) protein with antimicrobial activity. TPU is one of the most relevant materials used for medical devices with good mechanical properties but also good chemical resistance, which makes it difficult to modify. The chemical modification of TPU surfaces is achieved via a three-step procedure based on (i) TPU activation using hexamethylene diisocyanate (HDI); (ii) interfacial reaction with poly(ethylene glycol) (PEG) derivatives; and finally, (iii) a facile click reaction between the PEG-maleimide terminated assembled monolayers on the TPU and the cysteine (-thiol) termination of the recently designed recombinant human α-defensin 5 (HD5) protein. The obtained PEG based HD5 assembled monolayers on TPU were characterized using a surface science multitechnique approach including scanning electron microscopy, atomic force microscopy, contact angle, and X-ray photoelectron spectroscopy. The modified TPU surfaces with the HD5 protein derivative exhibit broad-spectrum antibacterial properties reducing biofilm formation against Pseudomonas aeruginosa (Gram-negative), methicillin-resistant Staphylococcus aureus (MRSA) (Gram-positive) and methicillin-resistant Staphylococcus epidermidis (MRSE) (Gram-positive). These findings underscore the substantial potential of protein-modified TPU surfaces for applications in combating bacterial infections associated with implantable materials and devices., Financial support by the MICIU of Spain (projects PID2019-105622RBI00, PID2020-115296RA-I00, PID2022-137332OB-I00, CEX2019-000917-S, CEX2023- 001263-S), CSIC (project 2023AEP092), the Marató de TV3 foundation (project number 201812-30-31-32-33 and 202326-30-31-32-33), and the Generalitat de Catalunya (project SGR Cat 2021-00438 and 2021-01552) is acknowledged. The authors are also grateful for the financial support received from Instituto de Salud Carlos III and the Networking Research Center on Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN). J.G. is grateful to the Max Planck Institute for Medical Research (Heidelberg, Germany) for their collaboration through the Max Planck Partner Group “Dynamic Biomimetics for Cancer Immunotherapy”. ICMAB-CSIC acknowledges support from the Severo Ochoa Programme for Centres of Excellence in R&D (FUNFUTURE, CEX2019-000917-S). J.M.M. received a personal 80:20 research grant from the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain, during 2017–24. This work has been developed inside the Materials Science PhD program of Universitat Autonoma de Barcelona. X.R.R. was supported by a grant PTA2021-020955-I funded by MCIN/AEI/10.13039/501100011033 and the FSE. This project has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No. 801342 (Tecniospring INDUSTRY) and the Government of Catalonia’s Agency for Business Competitiveness (ACCIO; TECSPR19-1-0065). A.L.-C. received a predoctoral fellowship from Generalitat de Catalunya (FI-AGAUR), and P.B. was supported by a PFIS predoctoral fellowship (FI20/00009) from the Instituto de Salud Carlos III. The authors also acknowledge the ICTS NANBIOSIS for the support of the Biomaterial Processing and Nanostructuring Unit (U6) at ICMAB-CSIC (https://www.nanbiosis.es/portfolio/u6-biomaterial-processing-and-nanostructuring-unit/)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S). With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2023-001263-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lymph-Node Inspired Hydrogels Enhance CAR Expression and Proliferation of CAR T Cells

  • Castellote Borrell, Miquel
  • Domingo, Marc
  • Merlina, Francesca
  • Lu, Huixia
  • Colell, Salut
  • Bachiller, Mireia
  • Juan, Manel
  • Guedan, Sonia
  • Faraudo, Jordi
  • Guasch, Judith
Chimeric antigen receptor (CAR) T therapy has shown unprecedented results in clinical practice, including long-term complete responses. One of the current challenges of CAR T therapy is to optimize its production in order to lower its cost. Currently, the in vivo activation of T cells by dendritic cells is replicated ex vivo using polymeric magnetic beads coated with antibodies to induce polyclonal T cell activation. However, current practice overlooks the importance of the complex environment that constitutes the lymph nodes, in which T cells activate and proliferate in vivo. Hydrogels are an ideal candidate material for mimicking the properties of natural tissues such as lymph nodes. In this study, key conditions of the composition, stiffness, and microarchitecture of hydrogels were experimentally and theoretically investigated to optimize primary human CAR T cell culture, focusing on CAR expression and proliferation. Poly(ethylene glycol)-heparin hydrogels featuring interconnected pores of 120 μm and an intermediate stiffness of 3.1 kPa were identified as the most suitable conditions for promoting CAR T cell expression and expansion. Specifically, these hydrogels increased the percentage of CAR+ cells by 50% and doubled the replication index compared to suspension cultures. In conclusion, these newly engineered hydrogels are an interesting tool to help improve CAR T cell manufacture and ultimately advance toward a broader clinical implementation of CAR T cell therapy., This research was supported by “La Caixa” Foundation through the program “CaixaImpulse” (grant no. CI23-20216) and the Spanish Government through grants CNS2023-144236 (MICIU/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR), 2024ICT149, PID2020-115296RA-I00 and PID2021-124297NB-C33 (MICIU/AEI/10.13039/501100011033), the “Severo Ochoa” program for Centers of Excellence awarded to ICMAB (CEX2023-001263 S), the FPI fellowships PRE2021-098161 and PRE2020-093689 awarded to M.C-B. and M.D., respectively, and the “Ramón y Cajal” program (RYC-2018-024442-I) granted to S.G. We also thank the Government of Catalonia (AGAUR) for the grant 2021SGR01519 as well as the Max Planck Society through the Max Planck Partner Group “Dynamic Biomimetics for Cancer Immunotherapy” in collaboration with the Max Planck for Medical Research (Heidelberg, Germany)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2023-001263-S)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Antibiofilm surfaces based on the immobilization of a novel recombinant antimicrobial multidomain protein using self-assembled monolayers

  • Kyvik, Adriana R.
  • Roca, Ramon
  • Mayolo-Deloisa, Karla
  • Rodriguez Rodriguez, Xavier
  • Martinez-Miguel, Marc
  • Martos, Marta
  • Köber, Mariana
  • Ventosa, Nora
  • Veciana, Jaume
  • Guasch, Judith
  • Garcia-Fruitos, Elena
  • Alomar, Oscar
  • Ratera, Imma
The constant increase of microorganisms resistant to antibiotics has been classified as a global health emergency, which is especially challenging when biofilms are formed. Herein, novel biofunctionalized gold surfaces with the antimicrobial multidomain recombinant protein JAMF1, both in the soluble form and nanostructured as nanoparticles, were developed. The interaction between His-tag termination of the protein and a nitriloacetic acid–Ni complex formed on mixed self-assembled monolayers (mixed SAMs) was exploited. The obtained antibiofilm surfaces based on the immobilization of the novel JAMF1 protein using self-assembled monolayers were characterized using a multi-technique approach including: cyclic voltammetry, X-ray photoelectron spectroscopy, atomic force microscopy and fluorescence, proving that the modification and immobilization of JAMF1 were successfully done. The antibiofilm activity against Escherichia coli and carbapenem-resistant Klebsiella pneumoniae showed that the immobilized antimicrobial proteins were able to reduce biofilm formation of both microorganisms. This strategy opens up new possibilities for controlled biomolecule immobilization for fundamental biological studies and biotechnological applications, at the interface of materials science and molecular biology., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Activating Thermoplastic Polyurethane Surfaces with Poly(ethylene glycol)-Based Recombinant Human α‑Defensin 5 Monolayers for Antibiofilm Activity

  • Rodríguez Rodríguez, Xavier
  • López-Cano, Adrià
  • Mayolo-Deloisa, Karla
  • Pich, Oscar Q.
  • Bierge, Paula
  • Ventosa, Nora
  • García-de-la-Maria, Cristina
  • Miró, José M.
  • Gasch, Oriol
  • Veciana, Jaume
  • Guasch, Judith
  • Arís, Anna
  • Garcia-Fruitos, Elena
  • Ratera, Imma
  • FUNCATH
Addressing multidrug-resistant microbial infections linked to implantable biomedical devices is an urgent need. In recent years, there has been an active exploration of different surface coatings to prevent and combat drug-resistant microbes. In this research, we present a facile chemical modification of thermoplastic polyurethane (TPU) surfaces with poly(ethylene glycol)-based recombinant human α-defensin 5 (HD5) protein with antimicrobial activity. TPU is one of the most relevant materials used for medical devices with good mechanical properties but also good chemical resistance, which makes it difficult to modify. The chemical modification of TPU surfaces is achieved via a three-step procedure based on (i) TPU activation using hexamethylene diisocyanate (HDI); (ii) interfacial reaction with poly(ethylene glycol) (PEG) derivatives; and finally, (iii) a facile click reaction between the PEG-maleimide terminated assembled monolayers on the TPU and the cysteine (-thiol) termination of the recently designed recombinant human α-defensin 5 (HD5) protein. The obtained PEG based HD5 assembled monolayers on TPU were characterized using a surface science multitechnique approach including scanning electron microscopy, atomic force microscopy, contact angle, and X-ray photoelectron spectroscopy. The modified TPU surfaces with the HD5 protein derivative exhibit broad-spectrum antibacterial properties reducing biofilm formation against Pseudomonas aeruginosa (Gram-negative), methicillin-resistant Staphylococcus aureus (MRSA) (Gram-positive) and methicillin-resistant Staphylococcus epidermidis (MRSE) (Gram-positive). These findings underscore the substantial potential of protein-modified TPU surfaces for applications in combating bacterial infections associated with implantable materials and devices., Financial support by the MICIU of Spain (projects PID2019105622RBI00, PID2020-115296RA-I00, PID2022-137332OBI00, CEX2019-000917-S, CEX2023- 001263-S), CSIC (project 2023AEP092), the Marató de TV3 foundation (project number 201812-30-31-32-33 and 202326-30-31-32-33), and the Generalitat de Catalunya (project SGR Cat 2021-00438 and 2021-01552) is acknowledged. The authors are also grateful for the financial support received from Instituto de Salud Carlos III and the Networking Research Center on Bioengineering, Biomaterials, and Nanomedicine (CIBERBBN). J.G. is grateful to the Max Planck Institute for Medical Research (Heidelberg, Germany) for their collaboration through the Max Planck Partner Group “Dynamic Biomimetics for Cancer Immunotherapy”. ICMAB-CSIC acknowledges support from the Severo Ochoa Programme for Centres of Excellence in R&D (FUNFUTURE, CEX2019-000917-S). J.M.M. received a personal 80:20 research grant from the Institut d’Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain, during 2017−24. This work has been developed inside the Materials Science PhD program of Universitat Autonoma de Barcelona. X.R.R. was supported by a grant PTA2021-020955-I funded by MCIN/AEI/10.13039/ 501100011033 and the FSE. This project has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No. 801342 (Tecniospring INDUSTRY) and the Government of Catalonia’s Agency for Business Competitiveness (ACCIO; TECSPR19-1-0065). A.L.-C. received a predoctoral fellowship from Generalitat de Catalunya (FIAGAUR), and P.B. was supported by a PFIS predoctoral fellowship (FI20/00009) from the Instituto de Salud Carlos III. The authors also acknowledge the ICTS NANBIOSIS for the support of the Biomaterial Processing and Nanostructuring Unit (U6) at ICMAB-CSIC (https://www.nanbiosis.es/ portfolio/u6-biomaterial-processing-and-nanostructuring-unit/, info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A Novel Generation of Tailored Antimicrobial Drugs Based on Recombinant Multidomain Proteins

  • López-Cano, Adrià
  • Ferrer-Miralles, Neus
  • Sánchez, Julieta
  • Carratalá, Jose Vicente
  • Rodriguez Rodriguez, Xavier
  • Ratera, Imma
  • Guasch, Judith
  • Pich, Oscar Q.
  • Bierge, Paula
  • Garcia-de-la-Maria, Cristina
  • Miro, Jose M.
  • Garcia-Fruitos, Elena
  • Alomar, Oscar
Antibiotic resistance has exponentially increased during the last years. It is necessary to develop new antimicrobial drugs to prevent and treat infectious diseases caused by multidrug- or extensively-drug resistant (MDR/XDR)-bacteria. Host Defense Peptides (HDPs) have a versatile role, acting as antimicrobial peptides and regulators of several innate immunity functions. The results shown by previous studies using synthetic HDPs are only the tip of the iceberg, since the synergistic potential of HDPs and their production as recombinant proteins are fields practically unexplored. The present study aims to move a step forward through the development of a new generation of tailored antimicrobials, using a rational design of recombinant multidomain proteins based on HDPs. This strategy is based on a two-phase process, starting with the construction of the first generation molecules using single HDPs and further selecting those HDPs with higher bactericidal efficiencies to be combined in the second generation of broad-spectrum antimicrobials. As a proof of concept, we have designed three new antimicrobials, named D5L37βD3, D5L37D5L37 and D5LAL37βD3. After an in-depth exploration, we found D5L37D5L37 to be the most promising one, since it was equally effective against four relevant pathogens in healthcare-associated infections, such as methicillin-susceptible (MSSA) and methicillin-resistant (MRSA) Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis (MRSE) and MDR Pseudomonas aeruginosa, being MRSA, MRSE and P. aeruginosa MDR strains. The low MIC values and versatile activity against planktonic and biofilm forms reinforce the use of this platform to isolate and produce unlimited HDP combinations as new antimicrobial drugs by effective means., info:eu-repo/semantics/publishedVersion
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Novel Generation of Tailored Antimicrobial Drugs Based on Recombinant Multidomain Proteins

  • López-Cano, Adrià
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Carratalá, José Vicente|||0000-0001-6950-2939
  • Rodriguez Rodriguez, Xavier
  • Ratera Bastardas, Imma|||0000-0002-1464-9789
  • Guasch, Judith|||0000-0002-3571-4711
  • Pich, Oscar Q.|||0000-0003-3561-630X
  • Bierge, Paula|||0000-0003-0917-3445
  • García de la Mària, Cristina|||0000-0002-0585-9469
  • Miró, José M.|||0000-0001-8057-7755
  • Garcia-Fruitos, Elena|||0000-0001-7498-4864
  • Arís i Giralt, Anna|||0000-0001-7830-888X
Antibiotic resistance has exponentially increased during the last years. It is necessary to develop new antimicrobial drugs to prevent and treat infectious diseases caused by multidrug- or extensively-drug resistant (MDR/XDR)-bacteria. Host Defense Peptides (HDPs) have a versatile role, acting as antimicrobial peptides and regulators of several innate immunity functions. The results shown by previous studies using synthetic HDPs are only the tip of the iceberg, since the synergistic potential of HDPs and their production as recombinant proteins are fields practically unexplored. The present study aims to move a step forward through the development of a new generation of tailored antimicrobials, using a rational design of recombinant multidomain proteins based on HDPs. This strategy is based on a two-phase process, starting with the construction of the first generation molecules using single HDPs and further selecting those HDPs with higher bactericidal efficiencies to be combined in the second generation of broad-spectrum antimicrobials. As a proof of concept, we have designed three new antimicrobials, named D5L37βD3, D5L37D5L37 and D5LAL37βD3. After an in-depth exploration, we found D5L37D5L37 to be the most promising one, since it was equally effective against four relevant pathogens in healthcare-associated infections, such as methicillin-susceptible (MSSA) and methicillin-resistant (MRSA) Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis (MRSE) and MDR Pseudomonas aeruginosa, being MRSA, MRSE and P. aeruginosa MDR strains. The low MIC values and versatile activity against planktonic and biofilm forms reinforce the use of this platform to isolate and produce unlimited HDP combinations as new antimicrobial drugs by effective means.